Pharmacodynamic-based clinical pathway for empiric antibiotic choice in patients with ventilator-associated pneumonia☆
To access this article, please choose from the options below
☆ This study was partially funded by AstraZeneca Pharmaceuticals LP, Wilmington, Del. E-test strips were graciously donated by AB Biodisk, Solna, Sweden. Drs Nicolau and Kuti are members of the speakers bureau, hired as consultants, and received research funding from AstraZeneca LP. All other authors have nothing to disclose.
PII: S0883-9441(09)00072-0
doi:10.1016/j.jcrc.2009.02.014
© 2010 Elsevier Inc. All rights reserved.
